Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Methyl α-Linolenyl Fluorophosphonate

Copy Product Info
😃Good
Catalog No. T22975

Methyl α-Linolenyl Fluorophosphonate is an inhibitor of phospholipases. Methyl α-Linolenyl Fluorophosphonate (MLnFP), an analog of methyl Arachidonyl Fuorophosphonate (MAFP), has not been completely investigated for its pharmacological activity.

Methyl α-Linolenyl Fluorophosphonate

Methyl α-Linolenyl Fluorophosphonate

Copy Product Info
😃Good
Catalog No. T22975
Methyl α-Linolenyl Fluorophosphonate is an inhibitor of phospholipases. Methyl α-Linolenyl Fluorophosphonate (MLnFP), an analog of methyl Arachidonyl Fuorophosphonate (MAFP), has not been completely investigated for its pharmacological activity.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
25 mgInquiry3-6 months3-6 months
50 mgInquiry3-6 months3-6 months
100 mgInquiry3-6 months3-6 months
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
Methyl α-Linolenyl Fluorophosphonate is an inhibitor of phospholipases. Methyl α-Linolenyl Fluorophosphonate (MLnFP), an analog of methyl Arachidonyl Fuorophosphonate (MAFP), has not been completely investigated for its pharmacological activity.
In vitro
In vitro: MethylArachidonyl Fluorophosphonate (MAFP) was reported to be a selective, active-site directed, irreversible inhibitor of cytosolic phospholipase A2 (cPLA2). MAFP could also potently inhibit the Ca2+-independent cytosolic phospholipase A2 (iPLA2) in a concentration-dependent manner. Such inhibition was not reversed upon extensive dilution of the enzyme into the assay mixture. The Preincubation of iPLA2 with MAFP led to a linear and time-dependent inactivation of enzyme activity, and the enzyme was protected from inactivation by the reversible inhibitor. The ability of MAFP to inhibit the iPLA 2 indicated that this enzyme proceeded via an acyl-enzyme intermediate. Further testing showed that MAFP could not inhibit the CoA-dependent acyltransferase, arachidonoyI-CoA synthetase, or CoA-independent transacylase activities. Therefore, MAFP was not a general inhibitor for enzymes acting on arachidonoyi substrates [1].
Chemical Properties
Molecular Weight344.4
FormulaC19H34FO2P
SmilesCC/C=C\C/C=C\C/C=C\CCCCCCCCP(=O)(F)OC
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
Ethanol: ≤5 mg/mL, Sonication is recommended.
DMSO: 5 mg/mL (14.52 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.9036 mL14.5180 mL29.0360 mL145.1800 mL
5 mM0.5807 mL2.9036 mL5.8072 mL29.0360 mL
10 mM0.2904 mL1.4518 mL2.9036 mL14.5180 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Methyl α-Linolenyl Fluorophosphonate | purchase Methyl α-Linolenyl Fluorophosphonate | Methyl α-Linolenyl Fluorophosphonate cost | order Methyl α-Linolenyl Fluorophosphonate | Methyl α-Linolenyl Fluorophosphonate chemical structure | Methyl α-Linolenyl Fluorophosphonate in vitro | Methyl α-Linolenyl Fluorophosphonate formula | Methyl α-Linolenyl Fluorophosphonate molecular weight